TGTX logo

TG Therapeutics (TGTX) Accounts payable

annual accounts payable:

N/A
December 31, 2024

Summary

  • TGTX annual accounts payable is not available.

Performance

TGTX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherTGTXbalance sheet metrics

quarterly accounts payable:

N/A
March 1, 2025

Summary

  • TGTX quarterly accounts payable is not available.

Performance

TGTX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherTGTXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

TGTX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

TGTX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

TGTX Accounts payable History

DateAnnualQuarterly
Sep 2020
-
$34.66M(+16.8%)
Jun 2020
-
$29.67M(-26.2%)
Mar 2019
-
$40.20M(+6.0%)
Sep 2018
-
$37.92M(+7.1%)
Jun 2018
-
$35.39M(+8.9%)
Mar 2018
-
$32.51M(+78.8%)
Sep 2017
-
$18.18M(-3.9%)
Mar 2017
-
$18.92M(+23.9%)
Dec 2016
$15.27M(+63.4%)
$15.27M(-1.8%)
Sep 2016
-
$15.55M(+18.9%)
Jun 2016
-
$13.08M(+60.7%)
Mar 2016
-
$8.14M(-12.9%)
Dec 2015
$9.35M(+134.1%)
$9.35M(+8.9%)
Sep 2015
-
$8.58M(+4.0%)
Jun 2015
-
$8.25M(-7.1%)
Mar 2015
-
$8.88M(+122.5%)
Dec 2014
$3.99M(-16.2%)
$3.99M(-49.9%)
Sep 2014
-
$7.97M(+319.5%)
Jun 2014
-
$1.90M(+15.9%)
Mar 2014
-
$1.64M(-65.6%)
Dec 2013
$4.76M(+326.4%)
$4.76M(+10.2%)
Sep 2013
-
$4.33M(+92.4%)
Jun 2013
-
$2.25M(+61.9%)
Mar 2013
-
$1.39M(+24.2%)
Dec 2012
$1.12M(+67.6%)
$1.12M(-37.9%)
Sep 2012
-
$1.80M(+459.3%)
Jun 2012
-
$321.70K(-31.2%)
Mar 2012
-
$467.50K(-29.9%)
Dec 2011
$666.60K(+198.3%)
$666.60K(+297.5%)
Sep 2011
-
$167.70K(-19.2%)
Jun 2011
-
$207.60K(+13.3%)
Mar 2011
-
$183.30K(-18.0%)
Dec 2010
$223.50K(-23.2%)
$223.50K(-43.5%)
Sep 2010
-
$395.80K(+5.9%)
Jun 2010
-
$373.80K(+23.5%)
Mar 2010
-
$302.70K(+3.9%)
Dec 2009
$291.20K
$291.20K(+103.5%)
Sep 2009
-
$143.10K(-17.2%)
DateAnnualQuarterly
Jun 2009
-
$172.90K(+19.7%)
Mar 2009
-
$144.50K(-73.4%)
Dec 2008
$542.30K(-57.6%)
$542.30K(-23.1%)
Sep 2008
-
$705.30K(+14.3%)
Jun 2008
-
$617.30K(-37.4%)
Mar 2008
-
$986.20K(-22.9%)
Dec 2007
$1.28M(-8.2%)
$1.28M(+50.1%)
Sep 2007
-
$852.50K(-14.9%)
Jun 2007
-
$1.00M(-34.3%)
Mar 2007
-
$1.52M(+9.4%)
Dec 2006
$1.39M(-13.9%)
$1.39M(+28.4%)
Sep 2006
-
$1.09M(-44.7%)
Jun 2006
-
$1.96M(-1.4%)
Mar 2006
-
$1.99M(+23.1%)
Dec 2005
$1.62M(+41.4%)
$1.62M(-5.6%)
Sep 2005
-
$1.71M(+31.5%)
Jun 2005
-
$1.30M(+17.2%)
Mar 2005
-
$1.11M(-2.8%)
Dec 2004
$1.14M(+108.5%)
$1.14M(-17.5%)
Sep 2004
-
$1.39M(+235.3%)
Jun 2004
-
$413.50K(-27.4%)
Mar 2004
-
$569.40K(+3.8%)
Dec 2003
$548.60K(+232.7%)
$548.60K(-27.9%)
Sep 2003
-
$760.50K(+32.5%)
Jun 2003
-
$574.00K(+21.2%)
Mar 2003
-
$473.70K(+187.3%)
Dec 2002
$164.90K(-67.6%)
$164.90K(-67.3%)
Sep 2002
-
$503.90K(+17.8%)
Jun 2002
-
$427.70K(-11.8%)
Mar 2002
-
$484.70K(-4.7%)
Dec 2001
$508.60K(-35.3%)
$508.60K(-32.0%)
Sep 2001
-
$748.40K(+5.9%)
Jun 2001
-
$706.90K(-9.3%)
Mar 2001
-
$779.20K(-0.8%)
Dec 2000
$785.80K(+57.2%)
$785.80K(-26.0%)
Sep 2000
-
$1.06M(+95.7%)
Jun 2000
-
$542.50K(+9.4%)
Mar 2000
-
$495.90K(-0.8%)
Dec 1999
$500.00K
$500.00K

FAQ

  • What is the all time high annual accounts payable for TG Therapeutics?
  • What is the all time high quarterly accounts payable for TG Therapeutics?

What is the all time high annual accounts payable for TG Therapeutics?

TG Therapeutics all-time high annual accounts payable is $15.27M

What is the all time high quarterly accounts payable for TG Therapeutics?

TG Therapeutics all-time high quarterly accounts payable is $40.20M
On this page